Third-Party Payor Clinical Trial Reimbursement Requires Persistence – Exec
This article was originally published in The Gray Sheet
Enlisting primary site investigators to contact third-party payors can aid in securing clinical trial reimbursement, according to Medtronic Sofamor Danek Reimbursement Group Director Robert Peterson
You may also be interested in...
SpineCore will begin a randomized, multi-site U.S. clinical trial for its FlexiCore intervertebral disc this month under a July 25 FDA investigational device exemption
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.